Page 3 - Acxp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) is one of 939 public companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its competitors? We will compare Acurx Pharmaceuticals to related businesses based on the strength of its valuation, institutional ownership, earnings, dividends, analyst recommendations, profitability and risk. Analyst Recommendations This is […]

Acurx Pharmaceuticals (NASDAQ:ACXP – Get Rating) issued its quarterly earnings data on Tuesday. The company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.33) by $0.07, MarketWatch Earnings reports. Shares of NASDAQ:ACXP traded down $0.69 during trading on Friday, hitting $2.61. 75,330 shares of the company were exchanged, compared to […]